文献速递关节外科

全髋关节置换术患者特异性脱位风险计算器的创建

Creation of a Total Hip Arthroplasty Patient-Specific Dislocation Risk Calculator.
PubMed 文献 · J Bone Joint Surg Am · 2022-04-22

该研究基于1998年至2018年间29,349例全髋关节置换术(其中初次置换21,978例、翻修7,371例),通过病历回顾定义不可变因素与可变的术中决策,建立多变量回归模型与列线图,计算术后1年和5年的脱位风险。初次置换者1年脱位风险为0.3%至13%、5年为0.4%至19%,翻修者1年为2%至32%、5年为3%至42%。列线图可用于筛选高脱位风险患者并个体化制定手术决策。

要点

  • 初次全髋关节置换术后1年脱位风险范围为0.3%至13%,5年为0.4%至19%。
  • 翻修全髋关节置换术后1年脱位风险范围为2%至32%,5年为3%至42%。
  • 初次置换中直接前入路(HR=0.27)与外侧入路(HR=0.58)较后入路降低脱位风险。

核心结论

  • 患者特异性脱位风险计算器基于纳入不稳定性相关合并症的多变量模型,显示基于合并症谱的患者特异性风险范围宽泛。
  • 所得列线图可用作筛查工具,识别全髋关节置换术后脱位高风险患者,并个体化制定基于证据的风险缓解手术决策。

研究设计与样本

  • 评估1998年至2018年间共29,349例全髋关节置换术,包括21,978例初次置换和7,371例翻修病例。
  • 平均随访6年期间,1,521例全髋关节置换术发生脱位。
  • 通过个体病历回顾,按不可变因素(人口学特征、全髋关节置换术指征、脊柱疾病、既往脊柱手术和神经系统疾病)和可变的术中决策(手术入路、股骨头直径和髋臼内衬类型[标准、高边、约束型或双动])对患者进行特征描述。
  • 以术后1年和5年脱位作为二分类结局,建立多变量回归模型和列线图。

主要发现

  • 初次全髋关节置换术后脱位风险基于患者特异性合并症和术中决策范围宽泛,1年为0.3%至13%,5年为0.4%至19%。
  • 翻修全髋关节置换术后脱位风险1年为2%至32%,5年为3%至42%。
  • 在初次全髋关节置换组中,直接前入路(风险比[HR]=0.27)和外侧入路(HR=0.58)较后入路降低脱位风险。
  • 在该组中调整入路后,≥36 mm直径股骨头联合高边内衬使脱位风险降低幅度最大(HR=0.28),其次为双动构造(HR=0.48)。
  • 在接受翻修全髋关节置换的患者中,调整后脱位风险降低最明显的是使用双动构造(HR=0.40),其次为≥36 mm股骨头联合高边内衬(HR=0.88);髋臼翻修使翻修全髋关节置换术后调整后脱位风险降低(HR=0.58),无论其他组件是否翻修。

关键数值与推荐

  • 初次全髋关节置换术后1年脱位风险范围为0.3%至13%,5年为0.4%至19%。
  • 翻修全髋关节置换术后1年脱位风险范围为2%至32%,5年为3%至42%。
  • 初次全髋关节置换中直接前入路HR=0.27,外侧入路HR=0.58(均以后入路为参照)。
  • 初次全髋关节置换中≥36 mm股骨头联合高边内衬HR=0.28,双动构造HR=0.48。
  • 翻修全髋关节置换中双动构造HR=0.40,≥36 mm股骨头联合高边内衬HR=0.88,髋臼翻修HR=0.58。

临床怎么用

  • 所得列线图可用作筛查工具,识别全髋关节置换术后脱位高风险患者。
  • 所得列线图可用于个体化制定基于证据的风险缓解手术决策。

局限性

  • 证据等级为预后Level IV。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Many risk factors have been described for dislocation following total hip arthroplasty (THA), yet a patient-specific risk assessment tool remains elusive. The purpose of this study was to develop a high-dimensional, patient-specific risk-stratification nomogram that allows dynamic risk modification based on operative decisions. METHODS: In this study, 29,349 THAs, including 21,978 primary and 7371 revision cases, performed between 1998 and 2018 were evaluated. During a mean 6-year follow-up, 1521 THAs were followed by a dislocation. Patients were characterized, through individual-chart review, according to non-modifiable factors (demographics, indication for THA, spine disease, prior spine surgery, and neurologic disease) and modifiable operative decisions (operative approach, femoral head diameter, and type of acetabular liner [standard, elevated, constrained, or dual-mobility]). Multivariable regression models and nomograms were developed with dislocation as a binary outcome at 1 year and 5 years postoperatively. RESULTS: Dislocation risk, based on patient-specific comorbidities and operative decisions, was wide-ranging-from 0.3% to 13% at 1 year and from 0.4% to 19% at 5 years after primary THA, and from 2% to 32% at 1 year and from 3% to 42% at 5 years after revision THA. In the primary-THA group, the direct anterior approach (hazard ratio [HR] = 0.27) and lateral approach (HR = 0.58) decreased the dislocation risk compared with the posterior approach. After adjusting for the approach in that group, the combination of a ≥36-mm-diameter femoral head and an elevated liner yielded the largest decrease in dislocation risk (HR = 0.28), followed by dual-mobility constructs (HR = 0.48). In the patients who underwent revision THA, the adjusted risk of dislocation was most markedly decreased by the use of a dual-mobility construct (HR = 0.40), followed by a ≥36-mm femoral head and an elevated liner (HR = 0.88). The adjusted risk of dislocation after revision THA was decreased by acetabular revision (HR = 0.58), irrespective of whether other components were revised. CONCLUSIONS: Our patient-specific dislocation risk calculator, which was strengthened by our use of a robust multivariable model that accounted for comorbidities associated with instability, demonstrated wide-ranging patient-specific risks based on comorbidity profiles. The resultant nomograms can be used as a screening tool to identify patients at high risk for dislocation following THA and to individualize operative decisions for evidence-based risk mitigation. LEVEL OF EVIDENCE: Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Wyles CC, Maradit-Kremers H, Larson DR, et al. Creation of a Total Hip Arthroplasty Patient-Specific Dislocation Risk Calculator. J Bone Joint Surg Am. 2022. PMID: 36149242. doi:10.2106/JBJS.21.01171

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。